141 related articles for article (PubMed ID: 37685295)
1. Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke.
Han E; Kim H; Cho B; Lee JJ; Shin S; Oh EJ; Chae H
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685295
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive Exdia TRF-LFIA for simultaneous quantification of GFAP and NT-proBNP in distinguishing ischemic and hemorrhagic stroke.
Lee M; Rafiq Sayyed D; Kim H; Sanchez JC; Sik Hong S; Choi S; Kim H; Han E; Won Kang H; Min Kim J; Joan M; Kim H; Chae H; Park JM
Clin Chim Acta; 2024 Apr; 557():117872. PubMed ID: 38471630
[TBL] [Abstract][Full Text] [Related]
3. Blood Biomarkers to Differentiate Ischemic and Hemorrhagic Strokes.
Bustamante A; Penalba A; Orset C; Azurmendi L; Llombart V; Simats A; Pecharroman E; Ventura O; Ribó M; Vivien D; Sanchez JC; Montaner J
Neurology; 2021 Apr; 96(15):e1928-e1939. PubMed ID: 33674361
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
Luger S; Jæger HS; Dixon J; Bohmann FO; Schaefer J; Richieri SP; Larsen K; Hov MR; Bache KG; Foerch C;
Neurocrit Care; 2020 Aug; 33(1):39-48. PubMed ID: 32096121
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L;
Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis.
Vergaro G; Castiglione V; Aimo A; Prontera C; Masotti S; Musetti V; Nicol M; Cohen Solal A; Logeart D; Georgiopoulos G; Chubuchny V; Giannoni A; Clerico A; Buda G; Patel KN; Razvi Y; Patel R; Wechalekar A; Lachmann H; Hawkins PN; Passino C; Gillmore J; Emdin M; Fontana M
Eur J Heart Fail; 2023 Mar; 25(3):335-346. PubMed ID: 36597836
[TBL] [Abstract][Full Text] [Related]
8. Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP.
Mattila OS; Ashton NJ; Blennow K; Zetterberg H; Harve-Rytsälä H; Pihlasviita S; Ritvonen J; Sibolt G; Nukarinen T; Curtze S; Strbian D; Pystynen M; Tatlisumak T; Kuisma M; Lindsberg PJ
Clin Chem; 2021 Oct; 67(10):1361-1372. PubMed ID: 34383905
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: A retrospective multicenter case-control study.
Zhao J; Zhang Y; Yuan F; Song C; Jiang Y; Gao Q; Leng X; Jiang W
J Neurol Sci; 2020 Jul; 414():116822. PubMed ID: 32278166
[TBL] [Abstract][Full Text] [Related]
10. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide and D-dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation.
Shen Z; Chen D; Cheng H; Tan F; Yan J; Deng H; Fang W; Wang S; Zhu J
Clin Cardiol; 2023 Jan; 46(1):41-48. PubMed ID: 36208092
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide predicts hospitalization for ischemic stroke in Japanese hemodialysis patients.
Yamaoka M; Yoshida M; Nakashima A; Doi S; Naito T; Masaki T
Clin Exp Nephrol; 2022 Nov; 26(11):1111-1118. PubMed ID: 35838853
[TBL] [Abstract][Full Text] [Related]
13. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.
Foerch C; Niessner M; Back T; Bauerle M; De Marchis GM; Ferbert A; Grehl H; Hamann GF; Jacobs A; Kastrup A; Klimpe S; Palm F; Thomalla G; Worthmann H; Sitzer M;
Clin Chem; 2012 Jan; 58(1):237-45. PubMed ID: 22125303
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
[TBL] [Abstract][Full Text] [Related]
16. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
18. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
[TBL] [Abstract][Full Text] [Related]
19. Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke.
Bunevicius A; Kazlauskas H; Raskauskiene N; Mickuviene N; Ndreu R; Corsano E; Bunevicius R
Neuroimmunomodulation; 2015; 22(6):365-72. PubMed ID: 25967464
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
